Date	Period	Revenue/Estimate	Earnings Call
Aug 9, 2024	2025/Q1	8.316B / --	--
Feb 13, 2024	2024/Q3	9.409B / --	--
Aug 10, 2023	2024/Q1	8.305B / --	--
Feb 10, 2023	2023/Q3	9.209B / --	--
Aug 9, 2022	2023/Q1	7.666B / --	--

DatePeriodRevenue/EstimateEarnings Call

Aug 9, 20242025/Q18.316B / ----

Feb 13, 20242024/Q39.409B / ----

Aug 10, 20232024/Q18.305B / ----

Feb 10, 20232023/Q39.209B / ----

Aug 9, 20222023/Q17.666B / ----

Unlock Free Earnings Estimates

Open Account

Toho Acetylene Earnings Reports

Toho Acetylene: Extraordinary Report

Dec 10, 2024 23:04 ET

Toho Acetylene: Confirmation letter

Nov 10, 2024 23:10 ET

Toho Acetylene: Half-Yearly Report - Term 91 (2024/04/01 - 2025/03/31)

Nov 10, 2024 23:09 ET

Toho Acetylene: Summary of financial results for the 2nd quarter (interim period) for the fiscal year ending March 31, 2025 [Japanese GAAP] (consolidated)

Nov 10, 2024 23:00 ET

Symbol Price % Chg

D. Western Therapeutics Institute

4576

201 +23.31%

See the daily top gainer.